Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

BUY
$7.94 - $12.36 $718,331 - $1.12 Million
90,470 New
90,470 $899,000
Q3 2021

Nov 12, 2021

SELL
$46.87 - $64.24 $2.18 Million - $2.98 Million
-46,457 Closed
0 $0
Q2 2021

Aug 17, 2021

SELL
$46.47 - $63.93 $2.79 Million - $3.84 Million
-60,053 Reduced 56.38%
46,457 $2.83 Million
Q1 2021

May 14, 2021

BUY
$55.47 - $72.35 $5.91 Million - $7.71 Million
106,510 New
106,510 $6.56 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.